Seminars in Oncology

Papers
(The H4-Index of Seminars in Oncology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
KRAS mutation in pancreatic cancer94
Axillary surgery in breast cancer: An updated historical perspective58
Just eat it: A review of CD47 and SIRP-α antagonism48
Systemic therapy for metastatic HER2-positive breast cancer47
Are sex discordant outcomes in COVID-19 related to sex hormones?41
Breast cancer survivorship31
Implications of reactive oxygen species on cancer formation and its treatment30
Cancer diagnosis in Brazil in the COVID-19 era30
The evolving management of metastatic triple negative breast cancer28
Novel radiation therapy approaches for breast cancer treatment27
Homologous recombination repair deficiency as a therapeutic target in sarcoma26
Chemotherapy-induced peripheral neuropathy and rehabilitation: A review25
Differences in mortality of cancer patients with COVID-19 in a Brazilian cancer center24
Management of ER positive metastatic breast cancer22
Management of hormone receptor-positive, HER2-negative early breast cancer22
Early stage triple negative breast cancer: Management and future directions21
Going viral: A brief history of Chilblain-like skin lesions (“COVID toes”) amidst the COVID-19 pandemic21
0.063977003097534